vs

Side-by-side financial comparison of CIRRUS LOGIC, INC. (CRUS) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $580.6M, roughly 1.2× CIRRUS LOGIC, INC.). Healthpeak Properties runs the higher net margin — 73.2% vs 24.2%, a 49.0% gap on every dollar of revenue. On growth, CIRRUS LOGIC, INC. posted the faster year-over-year revenue change (4.5% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $285.7M). Over the past eight quarters, CIRRUS LOGIC, INC.'s revenue compounded faster (25.0% CAGR vs 8.9%).

Cirrus Logic Inc. is an American fabless semiconductor supplier that specializes in analog, mixed-signal, and audio DSP integrated circuits (ICs). Since 1998, the company's headquarters have been in Austin, Texas.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

CRUS vs DOC — Head-to-Head

Bigger by revenue
DOC
DOC
1.2× larger
DOC
$719.4M
$580.6M
CRUS
Growing faster (revenue YoY)
CRUS
CRUS
+1.4% gap
CRUS
4.5%
3.1%
DOC
Higher net margin
DOC
DOC
49.0% more per $
DOC
73.2%
24.2%
CRUS
More free cash flow
DOC
DOC
$71.3M more FCF
DOC
$357.0M
$285.7M
CRUS
Faster 2-yr revenue CAGR
CRUS
CRUS
Annualised
CRUS
25.0%
8.9%
DOC

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CRUS
CRUS
DOC
DOC
Revenue
$580.6M
$719.4M
Net Profit
$140.3M
$114.0M
Gross Margin
53.1%
Operating Margin
26.3%
17.4%
Net Margin
24.2%
73.2%
Revenue YoY
4.5%
3.1%
Net Profit YoY
21.0%
2406.4%
EPS (diluted)
$2.66
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRUS
CRUS
DOC
DOC
Q4 25
$580.6M
$719.4M
Q3 25
$561.0M
$705.9M
Q2 25
$407.3M
$694.3M
Q1 25
$424.5M
$702.9M
Q4 24
$555.7M
$698.0M
Q3 24
$541.9M
$700.4M
Q2 24
$374.0M
$695.5M
Q1 24
$371.8M
$606.6M
Net Profit
CRUS
CRUS
DOC
DOC
Q4 25
$140.3M
$114.0M
Q3 25
$131.6M
$-117.1M
Q2 25
$60.7M
$31.7M
Q1 25
$71.3M
$42.8M
Q4 24
$116.0M
$4.5M
Q3 24
$102.1M
$85.9M
Q2 24
$42.1M
$146.0M
Q1 24
$44.8M
$6.7M
Gross Margin
CRUS
CRUS
DOC
DOC
Q4 25
53.1%
Q3 25
52.5%
58.6%
Q2 25
52.6%
60.2%
Q1 25
53.4%
61.1%
Q4 24
53.6%
60.3%
Q3 24
52.2%
60.0%
Q2 24
50.5%
60.6%
Q1 24
51.8%
59.8%
Operating Margin
CRUS
CRUS
DOC
DOC
Q4 25
26.3%
17.4%
Q3 25
25.8%
9.2%
Q2 25
17.8%
5.7%
Q1 25
20.2%
7.7%
Q4 24
26.2%
-2.2%
Q3 24
24.3%
14.1%
Q2 24
12.5%
22.3%
Q1 24
14.1%
3.7%
Net Margin
CRUS
CRUS
DOC
DOC
Q4 25
24.2%
73.2%
Q3 25
23.5%
-16.6%
Q2 25
14.9%
4.6%
Q1 25
16.8%
6.1%
Q4 24
20.9%
0.7%
Q3 24
18.8%
12.3%
Q2 24
11.3%
21.0%
Q1 24
12.1%
1.1%
EPS (diluted)
CRUS
CRUS
DOC
DOC
Q4 25
$2.66
$0.16
Q3 25
$2.48
$-0.17
Q2 25
$1.14
$0.05
Q1 25
$1.30
$0.06
Q4 24
$2.11
$0.02
Q3 24
$1.83
$0.12
Q2 24
$0.76
$0.21
Q1 24
$0.78
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRUS
CRUS
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$778.1M
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$2.1B
$7.5B
Total Assets
$2.5B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRUS
CRUS
DOC
DOC
Q4 25
$778.1M
$467.5M
Q3 25
$593.5M
$91.0M
Q2 25
$548.9M
$89.4M
Q1 25
$539.6M
$70.6M
Q4 24
$526.4M
$119.8M
Q3 24
$445.8M
$180.4M
Q2 24
$491.4M
$106.9M
Q1 24
$502.8M
$101.8M
Total Debt
CRUS
CRUS
DOC
DOC
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Q1 24
$8.8B
Stockholders' Equity
CRUS
CRUS
DOC
DOC
Q4 25
$2.1B
$7.5B
Q3 25
$2.0B
$7.6B
Q2 25
$1.9B
$7.9B
Q1 25
$1.9B
$8.2B
Q4 24
$2.0B
$8.4B
Q3 24
$1.9B
$8.6B
Q2 24
$1.8B
$8.8B
Q1 24
$1.8B
$8.9B
Total Assets
CRUS
CRUS
DOC
DOC
Q4 25
$2.5B
$20.3B
Q3 25
$2.4B
$19.6B
Q2 25
$2.3B
$19.8B
Q1 25
$2.3B
$19.8B
Q4 24
$2.4B
$19.9B
Q3 24
$2.4B
$20.0B
Q2 24
$2.3B
$20.2B
Q1 24
$2.2B
$20.5B
Debt / Equity
CRUS
CRUS
DOC
DOC
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRUS
CRUS
DOC
DOC
Operating Cash FlowLast quarter
$290.8M
$1.3B
Free Cash FlowOCF − Capex
$285.7M
$357.0M
FCF MarginFCF / Revenue
49.2%
49.6%
Capex IntensityCapex / Revenue
0.9%
124.4%
Cash ConversionOCF / Net Profit
2.07×
10.99×
TTM Free Cash FlowTrailing 4 quarters
$614.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRUS
CRUS
DOC
DOC
Q4 25
$290.8M
$1.3B
Q3 25
$92.2M
$315.0M
Q2 25
$116.1M
$363.5M
Q1 25
$130.4M
$279.4M
Q4 24
$218.6M
$1.1B
Q3 24
$8.2M
$318.2M
Q2 24
$87.2M
$316.2M
Q1 24
$170.5M
$152.6M
Free Cash Flow
CRUS
CRUS
DOC
DOC
Q4 25
$285.7M
$357.0M
Q3 25
$88.3M
Q2 25
$113.5M
Q1 25
$127.0M
Q4 24
$211.9M
$333.7M
Q3 24
$5.6M
Q2 24
$77.2M
Q1 24
$163.5M
FCF Margin
CRUS
CRUS
DOC
DOC
Q4 25
49.2%
49.6%
Q3 25
15.7%
Q2 25
27.9%
Q1 25
29.9%
Q4 24
38.1%
47.8%
Q3 24
1.0%
Q2 24
20.6%
Q1 24
44.0%
Capex Intensity
CRUS
CRUS
DOC
DOC
Q4 25
0.9%
124.4%
Q3 25
0.7%
Q2 25
0.6%
Q1 25
0.8%
Q4 24
1.2%
105.6%
Q3 24
0.5%
Q2 24
2.7%
Q1 24
1.9%
Cash Conversion
CRUS
CRUS
DOC
DOC
Q4 25
2.07×
10.99×
Q3 25
0.70×
Q2 25
1.91×
11.48×
Q1 25
1.83×
6.52×
Q4 24
1.88×
235.43×
Q3 24
0.08×
3.71×
Q2 24
2.07×
2.17×
Q1 24
3.80×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRUS
CRUS

Audio Products Segment$344.5M59%
High Performance Mixed Signal Products$236.2M41%

DOC
DOC

Segment breakdown not available.

Related Comparisons